I am honor to join @NarjustDumaMD and @ASCO @ConquerCancerFd to fund a YIA for Latinas in oncology conquer.org/WWCCGIFT @SandraSwainMD @EdithPerezMD @ASCOPres Please help us reach the goal! @HemOncWomenDocs

So happy to be here in San Francisco at the International Lobular Breast Cancer Symposium with some great scientists, physicians and most importantly patient advocates.#ILC needs more research and deserves its own treatment guidelines. We also desperately need more oncology and radiology provider education on how to recognize it on scans (e.g negative CT scans does not mean your mILC patient is ok) and the greater recognition of the common catastrophic complications that can occurr in mILC (hydronephrosis, bowel obstruction; GI bleeding and leptomeningeal carcinomatosis). The lobular breast cancer alliance is a huge resource for education and advocacy. If you want to learn more please go to lobularbreastcancer.org #breastcancer #lobular #lobmob

Honored to be a poster award candidate at #EANO2026 @EANOassociation for early data from our work on dose-reduced #belzutifan for #VHL- associated #hemangioblastoma @LevineCancer ~> ZERO pts have required surgery or SRS. Much more to come on this work! #btsm

My first #lead2026 was one for the books! - cancer updates - AI + medicine - mentorship -advocacy - negotiation - watched @rachnatshroff beautiful acceptance speech -woman oncologist of the yr We laughed + cried and came out stronger than ever! Cheers to this wolf pack!

I can’t think of anyone who has met @rachnatshroff and hasn’t been moved by her dynamic, vibrant spirit. Thousands are deeply inspired by her dedication to cancer research, #volunteerism, and #mentorship. Now, she is turning an incredibly difficult journey into a lasting legacy by raising funds to support future generations ❤️ We’re almost there. Let’s join hands and help make this extraordinary vision a reality. ❤️ support.conquer.org/p2p/site…

Check out this wonderful profile of Dr. Ann Partridge (@AnnPartridgeMD) in @NewBedfordLight, reflecting on her extraordinary career advancing #BreastCancer care and research, her commitment to young patients, and life as New Bedford’s “first lady.” newbedfordlight.org/dr-ann-p…

No woman should be told she cannot have hormones after breast cancer. CHOICES provides education and evidence review in oncology and hormone therapies. Not medical advice. No physician-patient relationship. Consult your own healthcare team. drbosserman.substack.com/p/w…

An unforgettable evening with the IASLC Board of Directors, celebrating global collaboration, meaningful connections, and our shared commitment to transforming lung cancer care. The work continues! 🌎🫁✨ #WCLC26

#WCLC26 🇰🇷 Pre-conference visit to the DMZ between North and South Korea. I was so captivated by the history of this place that the bus almost left without me! 😅 Beyond the stunning landscape, the DMZ is a powerful reminder of a divided history, separated families, and the lasting impact of war. A truly unforgettable experience.

When you and your partners show up to work on Friday looking remarkably similar... @SCRIOncology t-shirts 👚 + blue jeans 👖 + sneakers 👟 #Friday @SarahCannonDocs @MLJohnsonMD2 @MeredithMcKean

So excited to do this work alongside you @LaurenGroner

In this SABCS® Snippet, Drs. @KateIdaLathrop,@DrWGradishar and @SethWander join patient advocate @itsnot_pink to discuss camizestrant’s accelerated FDA approval and what the findings could mean for patients and clinical practice. @VKaklamani youtube.com/watch?v=BKf0AMby…

Even 20 years into radiology and medical education, the doubt still surfaces. Imposter syndrome never left me. The difference now is knowing that no one has it all figured out. If you’re willing to learn and adapt with humility, you belong in medicine.

Huge congrats to all the phenomenal folks pictured below including my longtime friend & collaborator @crisbergerot @oncoclinicas & my impressive colleague @batraatulonc from @aiims_newdelhi! Incredible impact from the @ConquerCancerFd grants - worldwide!

In 35 patients with TNBC and active brain metastases, adebrelimab + bevacizumab + platinum achieved: • CNS-ORR: 77.1% • CR: 14.3% • CNS-CBR: 80% • mCNS-PFS: 10.3 months Impressive—but which agent is driving this remarkable response? @OncoAlert @Larvol

What a wonderful surprise to see myself in this figure! 🌎🧡 Grateful to @ConquerCancerFd for supporting my journey through the 2021 ASCO GOYIA, and for continuing to invest in cancer researchers across the globe Cancer knows no borders @ASCO

1/ I was on the @FDAOncology ODAC for sotorasib, a KRAS G12Ci tested in NSCLC. We voted no, almost unanimously. A year later adagrasib + cetuximab got accelerated approval (AA) for colorectal cancer based on KRYSTAL-1. KRYSTAL-10 was a phase 3 RCT testing that combo and just reported negative findings. Last week adagrasib came off the market. I've already seen this called a failure of accelerated approval (AA). I'd argue the opposite.

All the women in medicine I’m not anymore in the pic. Growth isn’t only about what we achieve. Sometimes it’s about what we unlearn. For #WomenInMedicineMonth, I’m grateful for every version of me that got me here, and equally grateful I didn’t stay her. 💛

See you soon at #WCLC26 ! ✅ with ✈️ Part 1 of our adventure to 🇰🇷 from the 🏝️ ➡️ 🚕 Now a quick ride to JFK and 🔜 will be in route ✈️ to Seoul Excited to learn new and impactful data that can benefit patients with #LungCancer 🫁 in #PuertoRico @panoncology #LCSM

A true warrior has left us but her legacy will live forever. Sandi you left a mark in anyone that came close to you, I was privileged to have met you and work alongside with you. Your work impacted and inspired generations to come. You will be missed sweet friend.

Finally!! Sheparding in a new era. FDA Grants Accelerated Approval to a New Breast Cancer Treatment @oncoalert fda.gov/news-events/press-an…